Cargando…

Treatment of three-level cervical spondylotic myelopathy using ACDF or a combination of ACDF and ACCF

OBJECTIVES: This study aims to compare the outcomes between two anterior decompression and fusion techniques to treat multilevel cervical spondylotic myelopathy (MCSM). METHODS: After the screening for eligibility, a total of 66 patients were admitted to this study. These participants underwent ante...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Xiaoming, Zhao, Hongwei, Han, Felicity Y., Rudd, Samuel, Li, Zhaohui, Ding, Wenyuan, Yang, Sidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523112/
https://www.ncbi.nlm.nih.gov/pubmed/36189403
http://dx.doi.org/10.3389/fsurg.2022.1021643
_version_ 1784800199463403520
author Tian, Xiaoming
Zhao, Hongwei
Han, Felicity Y.
Rudd, Samuel
Li, Zhaohui
Ding, Wenyuan
Yang, Sidong
author_facet Tian, Xiaoming
Zhao, Hongwei
Han, Felicity Y.
Rudd, Samuel
Li, Zhaohui
Ding, Wenyuan
Yang, Sidong
author_sort Tian, Xiaoming
collection PubMed
description OBJECTIVES: This study aims to compare the outcomes between two anterior decompression and fusion techniques to treat multilevel cervical spondylotic myelopathy (MCSM). METHODS: After the screening for eligibility, a total of 66 patients were admitted to this study. These participants underwent anterior surgeries due to MCSM in our hospital between June 2016 and July 2018. All participants underwent either the anterior cervical discectomy and fusion (ACDF) surgery (ACDF group) or the combination of ACDF and anterior cervical corpectomy and fusion (ACCF), which was the anterior cervical hybrid decompression and fusion (ACHDF) surgery group. All the patients were followed up ≥18 months, the average latest followed up time was 23.64 (±2.69) months. The length of hospitalization, operation time, blood loss, visual analog scale (VAS), Japanese Orthopaedic Association (JOA) score, improvement rate, Hounsfield units (HU) of C3–C7, cobb angle, and anterior column height of fusion levels pre and post operation were analyzed. RESULTS: There were no statistical differences between the ACDF and ACHDF groups regarding the length of hospitalization, operation time, blood loss, HU of C3–C7, VAS, JOA score, improvement rate, cobb angle, and anterior column height in fusion levels in pre-operation and 3 months after operation (all P > 0.05). However, compared with the ACHDF group, the ACDF group achieved significantly better improvement in the anterior column height of fusion levels in the final 18–29 months post-operatively (P < 0.05). CONCLUSIONS: Both approaches of ACDF alone and a combination of ACDF and ACCF can achieve satisfactory outcomes in the treatment of MCSM, but ACDF has better outcomes in maintaining anterior column height of fusion levels.
format Online
Article
Text
id pubmed-9523112
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95231122022-10-01 Treatment of three-level cervical spondylotic myelopathy using ACDF or a combination of ACDF and ACCF Tian, Xiaoming Zhao, Hongwei Han, Felicity Y. Rudd, Samuel Li, Zhaohui Ding, Wenyuan Yang, Sidong Front Surg Surgery OBJECTIVES: This study aims to compare the outcomes between two anterior decompression and fusion techniques to treat multilevel cervical spondylotic myelopathy (MCSM). METHODS: After the screening for eligibility, a total of 66 patients were admitted to this study. These participants underwent anterior surgeries due to MCSM in our hospital between June 2016 and July 2018. All participants underwent either the anterior cervical discectomy and fusion (ACDF) surgery (ACDF group) or the combination of ACDF and anterior cervical corpectomy and fusion (ACCF), which was the anterior cervical hybrid decompression and fusion (ACHDF) surgery group. All the patients were followed up ≥18 months, the average latest followed up time was 23.64 (±2.69) months. The length of hospitalization, operation time, blood loss, visual analog scale (VAS), Japanese Orthopaedic Association (JOA) score, improvement rate, Hounsfield units (HU) of C3–C7, cobb angle, and anterior column height of fusion levels pre and post operation were analyzed. RESULTS: There were no statistical differences between the ACDF and ACHDF groups regarding the length of hospitalization, operation time, blood loss, HU of C3–C7, VAS, JOA score, improvement rate, cobb angle, and anterior column height in fusion levels in pre-operation and 3 months after operation (all P > 0.05). However, compared with the ACHDF group, the ACDF group achieved significantly better improvement in the anterior column height of fusion levels in the final 18–29 months post-operatively (P < 0.05). CONCLUSIONS: Both approaches of ACDF alone and a combination of ACDF and ACCF can achieve satisfactory outcomes in the treatment of MCSM, but ACDF has better outcomes in maintaining anterior column height of fusion levels. Frontiers Media S.A. 2022-09-16 /pmc/articles/PMC9523112/ /pubmed/36189403 http://dx.doi.org/10.3389/fsurg.2022.1021643 Text en © 2022 Tian, Zhao, Han, Rudd, Li, Ding and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Tian, Xiaoming
Zhao, Hongwei
Han, Felicity Y.
Rudd, Samuel
Li, Zhaohui
Ding, Wenyuan
Yang, Sidong
Treatment of three-level cervical spondylotic myelopathy using ACDF or a combination of ACDF and ACCF
title Treatment of three-level cervical spondylotic myelopathy using ACDF or a combination of ACDF and ACCF
title_full Treatment of three-level cervical spondylotic myelopathy using ACDF or a combination of ACDF and ACCF
title_fullStr Treatment of three-level cervical spondylotic myelopathy using ACDF or a combination of ACDF and ACCF
title_full_unstemmed Treatment of three-level cervical spondylotic myelopathy using ACDF or a combination of ACDF and ACCF
title_short Treatment of three-level cervical spondylotic myelopathy using ACDF or a combination of ACDF and ACCF
title_sort treatment of three-level cervical spondylotic myelopathy using acdf or a combination of acdf and accf
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523112/
https://www.ncbi.nlm.nih.gov/pubmed/36189403
http://dx.doi.org/10.3389/fsurg.2022.1021643
work_keys_str_mv AT tianxiaoming treatmentofthreelevelcervicalspondyloticmyelopathyusingacdforacombinationofacdfandaccf
AT zhaohongwei treatmentofthreelevelcervicalspondyloticmyelopathyusingacdforacombinationofacdfandaccf
AT hanfelicityy treatmentofthreelevelcervicalspondyloticmyelopathyusingacdforacombinationofacdfandaccf
AT ruddsamuel treatmentofthreelevelcervicalspondyloticmyelopathyusingacdforacombinationofacdfandaccf
AT lizhaohui treatmentofthreelevelcervicalspondyloticmyelopathyusingacdforacombinationofacdfandaccf
AT dingwenyuan treatmentofthreelevelcervicalspondyloticmyelopathyusingacdforacombinationofacdfandaccf
AT yangsidong treatmentofthreelevelcervicalspondyloticmyelopathyusingacdforacombinationofacdfandaccf